Cargando…
Outcomes Research and Drug Development
With increasing health care cost, focus needs to be given towards value-for-money, especially in the context of innovative drugs. A multi-disciplinary approach towards drug development is important in order to demonstrate the value of innovation to physicians and patients. Input into the drug develo...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications Pvt Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146074/ https://www.ncbi.nlm.nih.gov/pubmed/21814630 |
_version_ | 1782209156905697280 |
---|---|
author | Duttagupta, Sandeep |
author_facet | Duttagupta, Sandeep |
author_sort | Duttagupta, Sandeep |
collection | PubMed |
description | With increasing health care cost, focus needs to be given towards value-for-money, especially in the context of innovative drugs. A multi-disciplinary approach towards drug development is important in order to demonstrate the value of innovation to physicians and patients. Input into the drug development process at various stages of clinical trials must incorporate patient-focused endpoints and analyses. Demonstrating value of drugs will help ensure that innovative therapies should be seen as health care investment and not expense. |
format | Online Article Text |
id | pubmed-3146074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-31460742011-08-03 Outcomes Research and Drug Development Duttagupta, Sandeep Perspect Clin Res Clinical Research Methodology With increasing health care cost, focus needs to be given towards value-for-money, especially in the context of innovative drugs. A multi-disciplinary approach towards drug development is important in order to demonstrate the value of innovation to physicians and patients. Input into the drug development process at various stages of clinical trials must incorporate patient-focused endpoints and analyses. Demonstrating value of drugs will help ensure that innovative therapies should be seen as health care investment and not expense. Medknow Publications Pvt Ltd 2010 /pmc/articles/PMC3146074/ /pubmed/21814630 Text en Copyright: © Perspectives in Clinical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Research Methodology Duttagupta, Sandeep Outcomes Research and Drug Development |
title | Outcomes Research and Drug Development |
title_full | Outcomes Research and Drug Development |
title_fullStr | Outcomes Research and Drug Development |
title_full_unstemmed | Outcomes Research and Drug Development |
title_short | Outcomes Research and Drug Development |
title_sort | outcomes research and drug development |
topic | Clinical Research Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146074/ https://www.ncbi.nlm.nih.gov/pubmed/21814630 |
work_keys_str_mv | AT duttaguptasandeep outcomesresearchanddrugdevelopment |